Volume 7, Issue 5
Editorial
Treatment options for lupus nephritis: what lessons have we learned from the LUNAR study?
Author(s): BH Rovin
Brief Reportp. 469
Could blocking granulocyte�macrophage colony-stimulating factor action lead to a new treatment for inflammatory diseases?
Author(s): Bulletin Board
Brief Reportp. 469
Doctors and patients differ on perception of rheumatoid arthritis activity
Author(s): Bulletin Board
Brief Reportp. 470
Study reveals a DNA methylome signature in rheumatoid arthritis
Author(s): Bulletin Board
Special Interviewp. 473
Safety and efficacy of biologics, and the future direction of rheumatoid arthritis therapy
Author(s): EM Ruderman
Book Reviewp. 475
B lymphocytes may play a significant role in large-vessel vasculitis
Author(s): MA Alba, S Prieto-González, J Hernández-RodrÃÂÂguez & MC Cid
Short Reportp. 479
Maintaining remission in granulomatosis with polyangiitis (Wegener�s)
Author(s): E Reinhold-Keller & F Moosig
Review Articlep. 489
Recommendations and the state of the evidence for physical activity interventions for adults with rheumatoid arthritis: 2007 to present
Author(s): MD Iversen, M Brawerman & CN Iversen
Review Articlep. 505
Lupus patient education: an examination of approaches
Author(s): HL Breland & DL Kamen
Review Articlep. 527
Accelerated atherosclerosis in systemic lupus erythematosus: mechanisms and prevention approaches
Author(s): AJ Wilhelm & AS Major
Review Articlep. 541
Management of rheumatologic diseases in pregnancy
Author(s): O Ateka-Barrutia & C Nelson-Piercy
Review Articlep. 559
Prediction of response and adverse events to methotrexate treatment in patients with rheumatoid arthritis
Author(s): SMM Verstappen, S-A Owen & KL Hyrich
